June 23 (Reuters) - Immunovaccine Inc IMV.TO
* Awarded a subcontract by leidos to evaluate
immunovaccine's depovax(tm) platform for development of peptide
based malaria vaccine targets
Source text for Eikon: ID:nMKWGYP4La
Further company coverage: IMV.TO
(Bengaluru Newsroom: +1-646-223-8780)